BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo MX, Hua S, Shang QY. Application of nanotechnology in drug delivery systems for respiratory diseases (Review). Mol Med Rep 2021;23:325. [PMID: 33760125 DOI: 10.3892/mmr.2021.11964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Anwer MK, Ali EA, Iqbal M, Ahmed MM, Aldawsari MF, Saqr AA, Alalaiwe A, Soliman GA. Development of Chitosan-Coated PLGA-Based Nanoparticles for Improved Oral Olaparib Delivery: In Vitro Characterization, and In Vivo Pharmacokinetic Studies. Processes 2022;10:1329. [DOI: 10.3390/pr10071329] [Reference Citation Analysis]
2 Rana K, Kumar Pandey S, Chauhan S, Preet S. Anticancer therapeutic potential of 5-fluorouracil and nisin co-loaded chitosan coated silver nanoparticles against murine skin cancer. International Journal of Pharmaceutics 2022;620:121744. [DOI: 10.1016/j.ijpharm.2022.121744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Mukherjee D, Bhatt S. Biocomposite-based nanostructured delivery systems for treatment and control of inflammatory lung diseases. Nanomedicine (Lond) 2022. [PMID: 35477308 DOI: 10.2217/nnm-2021-0425] [Reference Citation Analysis]
4 Forest V, Pourchez J. Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient? Adv Drug Deliv Rev 2022;183:114173. [PMID: 35217112 DOI: 10.1016/j.addr.2022.114173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Othman SI, Adlii A, Allam AA, Alqhtani HA, Alhammadi AA, Abukhadra MR. Characterization of MgO/CaO hybrid nanorods as an enhanced inorganic carrier of 5-Fluorouracil drug; loading, release, and cytotoxicity studies. J Inorg Organomet Polym. [DOI: 10.1007/s10904-022-02256-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Alangari A, Alqahtani MS, Mateen A, Kalam MA, Alshememry A, Ali R, Kazi M, Alghamdi KM, Syed R, R L. Iron Oxide Nanoparticles: Preparation, Characterization, and Assessment of Antimicrobial and Anticancer Activity. Adsorption Science & Technology 2022;2022:1-9. [DOI: 10.1155/2022/1562051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
7 Jadhav P, Patil P, Bhagwat D, Gaikwad V, Mehta PP. Recent advances in orthogonal analytical techniques for microstructural understanding of inhalable particles: Present status and future perspective. Journal of Drug Delivery Science and Technology 2022;68:103089. [DOI: 10.1016/j.jddst.2021.103089] [Reference Citation Analysis]
8 Gupta S, Tejavath KK. Nano Phytoceuticals: A Step Forward in Tracking Down Paths for Therapy Against Pancreatic Ductal Adenocarcinoma. J Clust Sci. [DOI: 10.1007/s10876-021-02213-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alshetaili AS. Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines. Saudi J Biol Sci 2021;28:5065-73. [PMID: 34466084 DOI: 10.1016/j.sjbs.2021.05.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
10 Motawea A, Ahmed DAM, El-Mansy AA, Saleh NM. Crucial Role of PLGA Nanoparticles in Mitigating the Amiodarone-Induced Pulmonary Toxicity. Int J Nanomedicine 2021;16:4713-37. [PMID: 34267519 DOI: 10.2147/IJN.S314074] [Reference Citation Analysis]
11 Choi G, Piao H, Rejinold NS, Yu S, Kim KY, Jin GW, Choy JH. Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections. Pharmaceuticals (Basel) 2021;14:486. [PMID: 34069716 DOI: 10.3390/ph14050486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]